Interim results from a phase 2 pivotal study (DALY II USA) of tandem CD20-CD19-directed non-cryopreserved CAR-T cells - Zamtocabtagene autoleucel (Zamto-Cel) in patients with relapsed/refractory diffuse large B cell lymphoma Meeting Abstract
| Authors: | Shah, N. N.; Maziarz, R. T.; Jacobson, C. A.; Johnston, P. B.; Abhyankar, S.; Isufi, I.; Perales, M. A.; Ghosh, M.; Ulrickson, M.; Rosenthal, A. C.; Munoz, J. L.; Hardy, N. M.; Rapoport, A. P.; Karmali, R.; Awan, F. T.; McKinney, M. S.; Horwitz, M.; Lunning, M.; Denlinger, N.; Ancukiewicz, M.; Nallewar, M.; Coleman, K. C.; Eromosele, E.; Kaleta, R.; Theruvath, J.; Wijatyk, A.; Miklos, D. B. |
| Abstract Title: | Interim results from a phase 2 pivotal study (DALY II USA) of tandem CD20-CD19-directed non-cryopreserved CAR-T cells - Zamtocabtagene autoleucel (Zamto-Cel) in patients with relapsed/refractory diffuse large B cell lymphoma |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 69 |
| End Page: | 70 |
| Language: | English |
| ACCESSION: | WOS:001410860600017 |
| DOI: | 10.1182/blood-2024-208539 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
